- Home
- OCC vs RLYB Comparison
OCC vs RLYB Comparison
Compare OCC & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCC
- RLYB
- Stock Information
- Founded
- OCC 1983
- RLYB 2018
- Country
- OCC United States
- RLYB United States
- Employees
- OCC N/A
- RLYB N/A
- Industry
- OCC Telecommunications Equipment
- RLYB Biotechnology: Pharmaceutical Preparations
- Sector
- OCC Industrials
- RLYB Health Care
- Exchange
- OCC Nasdaq
- RLYB Nasdaq
- Market Cap
- OCC 39.9M
- RLYB 42.7M
- IPO Year
- OCC 1996
- RLYB 2021
- Fundamental
- Price
- OCC $4.86
- RLYB $0.88
- Analyst Decision
- OCC
- RLYB Buy
- Analyst Count
- OCC 0
- RLYB 6
- Target Price
- OCC N/A
- RLYB $8.10
- AVG Volume (30 Days)
- OCC 2.0M
- RLYB 94.1K
- Earning Date
- OCC 03-12-2025
- RLYB 03-11-2025
- Dividend Yield
- OCC N/A
- RLYB N/A
- EPS Growth
- OCC N/A
- RLYB N/A
- EPS
- OCC N/A
- RLYB N/A
- Revenue
- OCC $66,674,099.00
- RLYB $598,000.00
- Revenue This Year
- OCC N/A
- RLYB N/A
- Revenue Next Year
- OCC N/A
- RLYB N/A
- P/E Ratio
- OCC N/A
- RLYB N/A
- Revenue Growth
- OCC N/A
- RLYB N/A
- 52 Week Low
- OCC $2.02
- RLYB $0.84
- 52 Week High
- OCC $7.00
- RLYB $3.46
- Technical
- Relative Strength Index (RSI)
- OCC 70.26
- RLYB 37.61
- Support Level
- OCC $4.23
- RLYB $0.89
- Resistance Level
- OCC $5.17
- RLYB $0.95
- Average True Range (ATR)
- OCC 0.50
- RLYB 0.07
- MACD
- OCC 0.03
- RLYB -0.01
- Stochastic Oscillator
- OCC 82.49
- RLYB 4.74
About OCC Optical Cable Corporation
Optical Cable Corp manufactures tight-buffered fiber optic & copper data communication cables, data communication connectivity solutions for enterprise markets, and customized solutions for specialty use & harsh environments. Its products and services include designs and customized products for specialty applications and harsh environments, cabling, connectors, patch cords, assemblies, racks, cabinets, datacom enclosures, patch panels, faceplates, and multi-media boxes. The company supplies its products and services to industries such as the military, industrial, mining, petrochemical, renewable energy and broadcast applications, and for the wireless carrier market.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.